Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part II: cognitive-behavioral therapy

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC BRASILEIRA PSIQUIATRIA
Citação
BRAZILIAN JOURNAL OF PSYCHIATRY, v.45, n.5, p.431-447, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: To summarize evidence-based cognitive-behavioral therapy (CBT) treatment and propose clinical interventions for adult patients with obsessive-compulsive disorder (OCD).Methods: The literature on CBT interventions for adult OCD, including BT and exposure and response prevention, was systematically reviewed to develop updated clinical guidelines for clinicians, providing comprehensive details about the necessary procedures for the CBT protocol. We searched the literature from 2013-2020 in five databases (PubMed, Cochrane, Embase, PsycINFO, and Lilacs) regarding study design, primary outcome measures, publication type, and language. Selected articles were assessed for quality with validated tools. Treatment recommendations were classified according to levels of evidence developed by the American College of Cardiology and the American Heart Association.Results: We examined 44 new studies used to update the 2013 American Psychiatric Association guidelines. High-quality evidence supports CBT with exposure and response prevention techniques as a first-line treatment for OCD. Protocols for Internet-delivered CBT have also proven efficacious for adults with OCD.Conclusion: High-quality scientific evidence supports the use of CBT with exposure and response prevention to treat adults with OCD.
Palavras-chave
Obsessive-compulsive disorder, practice guideline, cognitive-behavioral therapy, exposure and response prevention, systematic review
Referências
  1. Abramowitz JS, 1996, BEHAV THER, V27, P583, DOI 10.1016/S0005-7894(96)80045-1
  2. Albert U, 2018, CURR MED CHEM, V25, P5647, DOI 10.2174/0929867325666171222163645
  3. Andersson E, 2014, PSYCHOL MED, V44, P2877, DOI 10.1017/S0033291714000543
  4. Andersson E, 2012, PSYCHOL MED, V42, P2193, DOI 10.1017/S0033291712000244
  5. Andrade L, 2002, SOC PSYCH PSYCH EPID, V37, P316, DOI 10.1007/s00127-002-0551-x
  6. [Anonymous], 2020, J PHYSIOTHER, V66, P59, DOI 10.1016/j.jphys.2019.08.005
  7. Ansari E, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2019-100180
  8. Asnaani A, 2017, COMPR PSYCHIAT, V73, P7, DOI 10.1016/j.comppsych.2016.10.004
  9. Associacao Brasileira de Psiquiatria, 2011, Transtorno obsessivo compulsivo: tratamento
  10. Belotto-Silva C, 2012, J ANXIETY DISORD, V26, P25, DOI 10.1016/j.janxdis.2011.08.008
  11. Chapman SCE, 2013, CURR OPIN PSYCHIATR, V26, P446, DOI 10.1097/YCO.0b013e3283642da4
  12. Chasson GS, 2010, BEHAV RES THER, V48, P675, DOI 10.1016/j.brat.2010.03.007
  13. Cottraux J, 2001, PSYCHOTHER PSYCHOSOM, V70, P288, DOI 10.1159/000056269
  14. Craske MG, 2008, BEHAV RES THER, V46, P5, DOI 10.1016/j.brat.2007.10.003
  15. Dadashi M, 2020, BASIC CLIN NEUROSCI, V11, P111, DOI 10.32598/bcn.11.1.13333.2
  16. de Leeuw AS, 2017, EUR PSYCHIAT, V40, P38, DOI 10.1016/j.eurpsy.2016.06.011
  17. Dèttore D, 2015, COGN BEHAV THERAPY, V44, P190, DOI 10.1080/16506073.2015.1005660
  18. Eddy KT, 2004, CLIN PSYCHOL REV, V24, P1011, DOI 10.1016/j.cpr.2004.08.004
  19. Eisen JL, 2010, J CLIN PSYCHIAT, V71, P1033, DOI 10.4088/JCP.08m04806blu
  20. Fineberg NA, 2020, INT CLIN PSYCHOPHARM, V35, P173, DOI 10.1097/YIC.0000000000000314
  21. Fineberg NA, 2018, INT CLIN PSYCHOPHARM, V33, P334, DOI 10.1097/YIC.0000000000000237
  22. Foa EB, 2015, J CLIN PSYCHIAT, V76, P440, DOI 10.4088/JCP.14m09044
  23. GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006
  24. Hezel DM, 2019, INDIAN J PSYCHIAT, V61, pS85, DOI 10.4103/psychiatry.IndianJPsychiatry_516_18
  25. Hohagen F, 1998, BRIT J PSYCHIAT, V173, P71, DOI 10.1192/S0007125000297924
  26. Hu XZ, 2015, PSYCHIAT RES, V229, P732, DOI 10.1016/j.psychres.2015.08.010
  27. Hu XZ, 2012, BRAIN BEHAV, V2, P443, DOI 10.1002/brb3.67
  28. Jacobs AK, 2013, CIRCULATION, V127, P268, DOI 10.1161/CIR.0b013e31827e8e5f
  29. Jelinek L, 2018, J ANXIETY DISORD, V56, P17, DOI 10.1016/j.janxdis.2018.03.012
  30. Koran LM, 2013, Practice guideline for the treatment of patients with obsessive-compulsive disorder
  31. Koran LM, 2007, AM J PSYCHIAT, V164, P5
  32. Külz AK, 2019, EUR ARCH PSY CLIN N, V269, P223, DOI 10.1007/s00406-018-0957-4
  33. Kyrios M, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9566
  34. Launes G, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02500
  35. Leeuwerik T, 2019, J ANXIETY DISORD, V68, DOI 10.1016/j.janxdis.2019.102135
  36. Ma JD, 2013, J PSYCHIATR RES, V47, P1785, DOI 10.1016/j.jpsychires.2013.08.002
  37. McCabe RE, 2019, J OBSESS-COMPULS REL, V22, DOI 10.1016/j.jocrd.2019.100446
  38. Mckay D, 2015, PSYCHIAT RES, V225, P236, DOI 10.1016/j.psychres.2014.11.058
  39. Meng FQ, 2019, J AFFECT DISORDERS, V253, P184, DOI 10.1016/j.jad.2019.04.090
  40. MEYER V, 1966, BEHAV RES THER, V4, P273, DOI 10.1016/0005-7967(66)90023-4
  41. National Institute for Health and Care Excellence, 2005, Obsessivecompulsive disorder and body dysmorphic disorder: treatment
  42. Oliveira M, 2023, Braz J Psychiatry, V45, P146
  43. Öst LG, 2015, CLIN PSYCHOL REV, V40, P156, DOI 10.1016/j.cpr.2015.06.003
  44. Ougrin D, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-200
  45. Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4
  46. Page MJ, 2021, J CLIN EPIDEMIOL, V134, P178, DOI [10.1136/bmj.n160, 10.1016/j.jclinepi.2021.03.001, 10.1016/j.jclinepi.2021.02.003, 10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]
  47. Pozza A, 2014, COGN BEH THER, V7, DOI 10.1017/S1754470X1400021X
  48. Ramos AL, 2022, EUR PSYCHIAT, V65, pS295, DOI 10.1192/j.eurpsy.2022.752
  49. RASMUSSEN SA, 1992, J CLIN PSYCHIAT, V53, P4
  50. Rector NA, 2019, BRIT J CLIN PSYCHOL, V58, P1, DOI 10.1111/bjc.12188
  51. Reddy YCJ, 2017, INDIAN J PSYCHIAT, V59, pS74, DOI 10.4103/0019-5545.196976
  52. Rupp C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213895
  53. Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94
  54. Santana L, 2013, J PSYCHIATR PRACT, V19, P42, DOI 10.1097/01.pra.0000426326.49396.97
  55. Sarichloo ME, 2020, IRAN J PSYCHIATRY BE, V14, DOI 10.5812/ijpbs.101535
  56. Schröder J, 2020, DEPRESS ANXIETY, V37, P1208, DOI 10.1002/da.23105
  57. Schwartze D, 2016, J OBSESS-COMPULS REL, V10, P49, DOI 10.1016/j.jocrd.2016.05.001
  58. Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008
  59. Simpson HB, 2013, JAMA PSYCHIAT, V70, P1190, DOI 10.1001/jamapsychiatry.2013.1932
  60. Skapinakis P, 2016, LANCET PSYCHIAT, V3, P730, DOI 10.1016/S2215-0366(16)30069-4
  61. Sousa MB, 2006, J CLIN PSYCHIAT, V67, P1133, DOI 10.4088/JCP.v67n0717
  62. Stein DJ, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0102-3
  63. Stewart KE, 2020, J AFFECT DISORDERS, V277, P159, DOI 10.1016/j.jad.2020.07.140
  64. Tenneij NH, 2005, J CLIN PSYCHIAT, V66, P1169, DOI 10.4088/JCP.v66n0913
  65. Tolin DF, 2007, BEHAV THER, V38, P179, DOI 10.1016/j.beth.2006.07.001
  66. Torres AR, 2006, AM J PSYCHIAT, V163, P1978, DOI 10.1176/appi.ajp.163.11.1978
  67. Twohig MP, 2018, BEHAV RES THER, V108, P1, DOI 10.1016/j.brat.2018.06.005
  68. Vaccaro LD, 2014, CLIN PSYCHOL-UK, V18, P74, DOI 10.1111/cp.12019
  69. van Balkom AJLM, 1998, J NERV MENT DIS, V186, P492, DOI 10.1097/00005053-199808000-00007
  70. van Balkom AJLM, 2012, PSYCHOTHER PSYCHOSOM, V81, P366, DOI 10.1159/000339369
  71. VANBALKOM AJLM, 1994, CLIN PSYCHOL REV, V14, P359, DOI 10.1016/0272-7358(94)90033-7
  72. Visser HA, 2015, PSYCHOTHER PSYCHOSOM, V84, P284, DOI 10.1159/000382131
  73. Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6
  74. Wootton BM, 2019, J ANXIETY DISORD, V66, DOI 10.1016/j.janxdis.2019.102111
  75. Wootton BM, 2013, J OBSESS-COMPULS REL, V2, P375, DOI 10.1016/j.jocrd.2013.07.002